PROCEPT BioRobotics Corporation Common Stock(PRCT)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $19.35 – $62.17
- YTD
- -15.73%
- IV Rank (30D)
- 22.26
- Straddle Price
- $4.28
- P/C Vol Ratio
- 0.88
- Market Cap
- $1.5B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.53% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 10.03% (VRP-adj) |
| WACC | 9.80% |
| Volatility Risk Premium | +16.5pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +5.0% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.05 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.1B |
| Return on Equity (TTM) | -29.5% |
| Book / Price | 22.5% |
| Gross Margin (TTM) | 64.0% |
| FCF Margin (TTM) | -25.0% |
| Debt / Equity | 0.15 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $25.74 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $27.38 |
| Bollinger Width / SMA20 | 56.2% (drives anchor stability) |
| Net Debt | $-0.2B |
| Market Cap | $2B |
| Horizon | Expected α | z Pred | Blended z | Rank % | Active? |
|---|---|---|---|---|---|
| 21d | -2.7% ⚠ | +0.07 | +1.05 | 77.6% | — |
| 42d | -0.3% ⚠ | +0.98 | +1.50 | 87.1% | — |
| 63d | +5.3% | +1.84 | +1.93 | 94.0% | ACTIVE |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 32.7× · 6 peers |
| Peer EV/EBITDA | n/a | 0% | median 20.3× · 6 peers |
| Peer P/B | $50.96 | 50% | median 8.2× · 8 peers |
| Peer P/S | $29.75 | 50% | median 4.9× · 8 peers |
| Market Anchor (SMA50) | $25.74 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841)
- Exchange
- XNAS
- Market Cap
- $1.5B
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -7.89% | 5 |
| Feb | +1.04% | 5 |
| Mar | +4.53% | 5 |
| Apr | +2.80% | 5 |
| May | +10.99% | 5 |
| Jun | -5.07% | 5 |
| Jul | +3.44% | 4 |
| Aug | +8.53% | 4 |
| Sep | -0.82% | 5 |
| Oct | -1.36% | 5 |
| Nov | -1.03% | 5 |
| Dec | -7.52% | 5 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-08-01 | After-Close | 27.37% | 8.69% | 0.32x | Within |
| 2024-10-28 | Pre-Market | 23.33% | 25.95% | 1.11x | Exceeded |
| 2025-02-25 | After-Close | 20.26% | 1.42% | 0.07x | Within |
| 2025-04-24 | Pre-Market | 19.57% | 9.38% | 0.48x | Within |
| 2025-08-06 | After-Close | 14.61% | 13.35% | 0.91x | Within |
| 2025-11-04 | After-Close | 23.27% | 9.74% | 0.42x | Within |
| 2026-02-25 | After-Close | 21.03% | 15.26% | 0.73x | Within |
| 2026-04-29 | After-Close | 21.65% | 10.73% | 0.50x | Within |
- IV Rank (30D)
- 22.26
- IV Rank (7D)
- 100
- Avg IV
- 91.4%
- Straddle (30D)
- $4.28
- Straddle (7D)
- $2.10
- P/C Volume
- 0.88
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
- Beta (1Y vs SPY)
- 0.95
- Correlation (SPY)
- 19.4%
- R²
- 0.04
- Ann. Volatility
- 60.2%
- SPY Volatility
- 12.3%
Moderate volatility - stock generally follows market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Divisadero Street Capital Management, LP | $14.36M | 41.71% | 2026-03-31 |
| 2 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $8.06M | 23.40% | 2026-03-31 |
| 3 | JANE STREET GROUP, LLC Custodian | $3.24M | 9.42% | 2026-03-31 |
| 4 | GROUP ONE TRADING LLC Custodian | $2.73M | 7.93% | 2026-03-31 |
| 5 | Eagle Health Investments LP | $2.25M | 6.54% | 2026-03-31 |
| 6 | IMC-Chicago, LLC Custodian | $975.39K | 2.83% | 2026-03-31 |
| 7 | WOLVERINE TRADING, LLC Custodian | $678.71K | 1.97% | 2025-09-30 |
| 8 | CITADEL ADVISORS LLC Custodian | $537.72K | 1.56% | 2026-03-31 |
| 9 | MILLENNIUM MANAGEMENT LLC Custodian | $500.20K | 1.45% | 2026-03-31 |
| 10 | Cubist Systematic Strategies, LLC | $403.30K | 1.17% | 2025-09-30 |
| 11 | SIMPLEX TRADING, LLC Custodian | $382.65K | 1.11% | 2026-03-31 |
| 12 | Point72 Asset Management, L.P. | $285.11K | 0.83% | 2026-03-31 |
| 13 | Walleye Trading LLC | $20.01K | 0.06% | 2026-03-31 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $2.21M | 35.79% | 2026-03-31 |
| 2 | CITADEL ADVISORS LLC Custodian | $1.34M | 21.71% | 2026-03-31 |
| 3 | IMC-Chicago, LLC Custodian | $977.89K | 15.86% | 2026-03-31 |
| 4 | JANE STREET GROUP, LLC Custodian | $950.38K | 15.42% | 2026-03-31 |
| 5 | SIMPLEX TRADING, LLC Custodian | $270.11K | 4.38% | 2026-03-31 |
| 6 | Cubist Systematic Strategies, LLC | $214.14K | 3.47% | 2025-09-30 |
| 7 | Walleye Trading LLC | $147.56K | 2.39% | 2026-03-31 |
| 8 | GROUP ONE TRADING LLC Custodian | $60.02K | 0.97% | 2026-03-31 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-10 | Barry L Templin | EVP, Chief Technology Officer | Sell (S) | −358 | $28.48 | -$10.2K | EDGAR |
| 2026-06-10 | Kevin Waters | EVP, CFO | Sell (S) | −357 | $28.48 | -$10.2K | EDGAR |
| 2026-06-10 | Antal Rohit Desai | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | THOMAS M PRESCOTT | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | Elisabeth Sandoval Little | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (S) | −285 | $28.48 | -$8.1K | EDGAR |
| 2026-06-10 | Amy M. Dodrill | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | Taylor C. Harris | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | Mary Garrett | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | DAN PUCKETT | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-06-10 | FREDERIC H MOLL | Director | Award (A) | +3,315 | — | EDGAR | |
| 2026-03-19 | Kevin Waters | EVP, CFO | Sell (S) | −706 | $28.15 | -$19.9K | EDGAR |
| 2026-03-19 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (S) | −304 | $28.15 | -$8.6K | EDGAR |
| 2026-03-19 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (S) | −5,363 | $25.96 | -$139.2K | EDGAR |
| 2026-03-12 | Alaleh Nouri | EVP, CLO, CORP. SEC. | Sell (S) | −3,243 | $25.65 | -$83.2K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David C. Ott | 10%+ Owner | 3,715,170 | $95.50M | $112.00M | 1 | 2021-09-21 |
| 2 | Viking Global Opportunities Portfolio GP LLC | 10%+ Owner | 3,360,687 | $86.39M | -$336.11M | 1 | 2022-03-22 |
| 3 | CPMG Inc | 10%+ Owner | 2,828,204 | $72.70M | $33.00M | 4 | 2024-05-07 |
| 4 | FREDERIC H MOLL | Director | 866,474 | $22.27M | $7.72M | 9 | 2026-06-10 |
| 5 | Antal Rohit Desai | Director | 463,429 | $11.91M | -$14.65M | 20 | 2026-06-10 |
| 6 | Larry L Wood | President, CEO | 313,378 | $8.06M | $0 | 5 | 2026-03-09 |
| 7 | White Tailed Ptarmigan, LP | 10%+ Owner | 261,862 | $6.73M | $0 | 3 | 2022-12-07 |
| 8 | Reza Zadno | President, CEO | 186,829 | $4.80M | -$38.48M | 20 | 2025-05-13 |
| 9 | Kevin Waters | EVP, CFO | 151,201 | $3.89M | -$13.24M | 23 | 2026-06-10 |
| 10 | Taylor C. Harris | Director | 137,565 | $3.54M | $250.0K | 7 | 2026-06-10 |
| 11 | Morgan Colby Wood | Director | 115,625 | $2.97M | -$1.07M | 8 | 2023-11-14 |
| 12 | Alaleh Nouri | EVP, CLO, CORP. SEC. | 105,069 | $2.70M | -$10.85M | 28 | 2026-06-10 |
| 13 | Hisham Shiblaq | EVP, Chief Comm. Officer | 70,837 | $1.82M | -$5.06M | 12 | 2025-06-06 |
| 14 | Barry L Templin | EVP, Chief Technology Officer | 68,953 | $1.77M | -$10.2K | 1 | 2026-06-10 |
| 15 | Thomas M Krummel | Director | 47,007 | $1.21M | -$2.77M | 8 | 2024-06-06 |
| 16 | Mary Garrett | Director | 17,700 | $455.0K | $0 | 6 | 2026-06-10 |
| 17 | Elisabeth Sandoval Little | Director | 15,876 | $408.1K | $0 | 6 | 2026-06-10 |
| 18 | Amy M. Dodrill | Director | 10,941 | $281.2K | $0 | 5 | 2026-06-10 |
| 19 | DAN PUCKETT | Director | 8,791 | $226.0K | $0 | 2 | 2026-06-10 |
| 20 | THOMAS M PRESCOTT | Director | 7,211 | $185.4K | $0 | 3 | 2026-06-10 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/B Ratio | 4.5 |
| P/S Ratio | 4.9 |
| EV/EBITDA | -13.5 |
| TTM Revenue | $0.3B |
| TTM Net Income | $-0.1B |
| TTM EPS | $-1.82 |
| ROE | -29.5% |
| Debt/Equity | 0.15 |